首页>
外国专利>
INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND alpha V beta 3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY
INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND alpha V beta 3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY
展开▼
机译:内皮素信号通路的抑制剂和αV beta 3整合素受体拮抗剂用于联合治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to the use of an endothelin blocker in combination with an alpha v beta 3 integrin receptor antagonist for the treatment or prevention of diseases, particularly to the use of a pharmaceutical composition, comprising an endothelin blocker and an alpha v beta 3 integrin receptor antagonist, for the treatment or prevention of cardiovascular disorders, particularly for the treatment or prevention of restenosis after vessel injury or revascularisation treatment and to the pharmaceutical composition itself.
展开▼